Bharat Biotech thanks PM Modi, saying Obliged to contribute to Aatmanirbhar Bharat ANI | Updated: Jan 03, 2021 20:53 IST
Hyderabad (Telangana) [India], January 3 (ANI): Soon after Prime Minister Narendra Modi applauded the scientists for obtaining emergency use approval from Drugs Controller General of India (DCGI) for indigenous vaccines against COVID-19 on Sunday, the developer of Covaxin, Bharat Biotech, a Hyderabad-based firm expressed its gratitude to him. Respected Sir, We are honoured! Thank you for your faith in our nation s vaccine and constant motivation. We are much obliged to contribute to Aatmanirbhar Bharat, tweeted Bharat Biotech.
Prime Minister Narendra Modi congratulated the country as DCGI granted emergency use approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines on Sunday.
Updated Jan 03, 2021 | 13:41 IST
Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses. Representational Image
Hyderabad: Expressing delight on the Ministry of Health & Family Welfare announcement and the statement from DCGI - Central Standards Control Organization (CDSCO) Grant of permission for emergency use of its Covid-19 Vaccine today, the Chairman and Managing Director of Bharat Biotech Dr Krishna Ella said “The approval of COVAXIN™ for emergency use is a giant leap for Innovation and novel product development in India. It is a proud moment for the nation and a great milestone in India’s scientific capability, a kickstart to the innovation ecosystem in India. While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the mo